Triosephosphate isomerase- and glyceraldehyde-3-phosphate dehydrogenase-reactive autoantibodies in the cerebrospinal fluid of patients with multiple sclerosis. 2006

Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
Department of Neurology, University of California, Irvine, CA 92697, USA.

Our previous results revealed that Igs in lesions and single chain variable fragment Abs (scFv-Abs) generated from clonal B cells in the cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) bind to axons in MS brains. To study the axonal Ags involved in MS, we identified the glycolytic enzymes, triosephosphate isomerase (TPI) and GAPDH, using Igs from the CSF and scFv-Abs generated from clonal B cells in the CSF and in lesions from MS patients. Elevated levels of CSF-Abs to TPI were observed in patients with MS (46%), clinically isolated syndrome (CIS) suggestive of MS (40%), other inflammatory neurological diseases (OIND; 29%), and other noninflammatory neurological diseases (ONIND; 31%). Levels of GAPDH-reactive Abs were elevated in MS patients (60%), in patients with CIS (10%), OIND (14%), and ONIND (8%). The coexistence of both autoantibodies was detected in 10 MS patients (29%), and 1 CIS patient (3%), but not in patients with OIND/ONIND. Two scFv-Abs generated from the CSF and from lesions of a MS brain showed immunoreactivity to TPI and GAPDH, respectively. The findings suggest that TPI and GAPDH may be candidate Ags for an autoimmune response to neurons and axons in MS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D005260 Female Females
D005987 Glyceraldehyde-3-Phosphate Dehydrogenases Enzymes that catalyze the dehydrogenation of GLYCERALDEHYDE 3-PHOSPHATE. Several types of glyceraldehyde-3-phosphate-dehydrogenase exist including phosphorylating and non-phosphorylating varieties and ones that transfer hydrogen to NADP and ones that transfer hydrogen to NAD. GAPD,Glyceraldehyde-3-Phosphate Dehydrogenase,Glyceraldehydephosphate Dehydrogenase,Phosphoglyceraldehyde Dehydrogenase,Triosephosphate Dehydrogenase,Dehydrogenase, Glyceraldehyde-3-Phosphate,Dehydrogenase, Glyceraldehydephosphate,Dehydrogenase, Phosphoglyceraldehyde,Dehydrogenase, Triosephosphate,Dehydrogenases, Glyceraldehyde-3-Phosphate,Glyceraldehyde 3 Phosphate Dehydrogenase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
August 2010, Journal of immunology (Baltimore, Md. : 1950),
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
February 1985, Biochemistry,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
June 1955, The American journal of physiology,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
November 1978, Human genetics,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
August 1969, The Biochemical journal,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
April 1998, Microbiology (Reading, England),
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
June 1971, European journal of biochemistry,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
December 1976, Biochemistry,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
January 1995, Planta,
Johanna Kolln, and Hui-Min Ren, and Reng-Rong Da, and Yiping Zhang, and Edzard Spillner, and Michael Olek, and Neal Hermanowicz, and Lutz G Hilgenberg, and Martin A Smith, and Stanley van den Noort, and Yufen Qin
February 1974, Analytical biochemistry,
Copied contents to your clipboard!